Peter Pitts on Healthcare Bill's Passage in US House
RECENT NEWS
New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases
Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more
Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs
Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more
PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD
How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo... Read more